Showing results (351-360 of 379) with videos related to

Sort By:
Pageof 38
Oral Oncology|January 11, 2024
Association Between Social Determinants of Health, Distance from Treatment Center, and Treatment Type with Outcomes in Human Papillomavirus Associated Oropharyngeal cancerAisha A Aden, Felicia O Olawuni, Chadi N Abdel-Halim, et al.
Advances in Radiation Oncology|July 11, 2022
The Number of Radiographically Positive Lymph Nodes Further Stratifies Patient Survival Among Clinical N1 Patients With Human Papillomavirus-Associated Oropharyngeal CancerRoman O Kowalchuk, Kathryn M Van Abel, Adam B Sauer, et al.
Frontiers in Oncology|May 28, 2021
Predicting Adverse Pathologic Features and Clinical Outcomes of Resectable Pancreas Cancer With Preoperative CA 19-9Roman O Kowalchuk, Scott C Lester, Rondell P Graham, et al.
The Journal of Clinical Investigation|February 1, 2024
HER2 heterogeneity and treatment response-associated profiles in HER2-positive breast cancer in the NCT02326974 clinical trialZheqi Li, Otto Metzger Filho, Giuseppe Viale, et al.
Cancers|January 23, 2024
Mean Oral Cavity Organ-at-Risk Dose Predicts Opioid Use and Hospitalization during Radiotherapy for Patients with Head and Neck TumorsRobert L Foote, W Scott Harmsen, Adam C Amundson, et al.
Leukemia & Lymphoma|September 24, 2020
Analysis and impact of a multidisciplinary lymphoma virtual tumor boardThomas M Habermann, Arushi Khurana, Ruth Lentz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2020
Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancerGohar S Manzar, Scott C Lester, David M Routman, et al.
International Journal of Radiation Oncology, Biology, Physics|December 23, 2022
Don't Put the CART Before the Horse: The Role of Radiation Therapy in Peri-CAR T-cell Therapy for Aggressive B-cell Non-Hodgkin LymphomaOmran Saifi, William G Breen, Scott C Lester, et al.
Haematologica|June 15, 2023
Consolidative radiotherapy for residual fluorodeoxyglucose activity on day +30 post CAR T-cell therapy in non-Hodgkin lymphomaOmran Saifi, William G Breen, Scott C Lester, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 31, 2026
Optimizing low dose radiotherapy for indolent lymphomas: comparing 8 Gy in 2 fractions to 4 Gy in 2 fractionsJessica F Burlile, William S Harmsen, Sydney D Suddendorf, et al.
Pageof 38